Elsevier

Clinica Chimica Acta

Volume 104, Issue 1, 21 May 1980, Pages 11-23
Clinica Chimica Acta

Serum high density lipoprotein cholesterol in diabetes mellitus: An analysis of factors which influence its concentration

https://doi.org/10.1016/0009-8981(80)90130-8Get rights and content

Abstract

The study assesses whether diabetes has an effect on serum high density lipoprotein (HDL) cholesterol concentration independent of other factors known to influence serum HDL cholesterol concentration. Concentrations of serum HDL cholesterol, serum cholesterol, serum M particles and blood sugar, and the proportion of haemoglobin in the form of HbA1 were measured in a diabetic and a non-diabetic population. Relative body weight, alcohol and cigarette consumption, age, a clinical estimate of diabetic control and duration of diabetes were also recorded. The diabetic patients were divided into those in whom insulin treatment was clinically indicated and those in whom it was not.

Serum HDL cholesterol concentration was significantly higher in diabetic men treated with insulin than in normal men and also higher in diabetic women treated with insulin than in normal women. In the diabetic men and women not treated with insulin, serum HDL cholesterol concentration was not significantly different from normal. There were differences between the diabetic and non-diabetic populations in terms of factors known to influence serum HDL cholesterol and also in the degree of correlation between these and the serum HDL cholesterol. Multivariate analysis revealed that in both male and female diabetic patients treated with insulin, diabetes was a highly significant influence on serum HDL cholesterol concentration, but in the non-insulin-treated diabetic patients the influence was absent in women and only marginal in men. The proportion of HbA1 influenced serum HDL cholesterol concentration negatively in insulin-treated diabetes but not in diabetes treated without insulin.

References (37)

  • T. Gordon et al.

    Am. J. Med.

    (1977)
  • N.E. Miller et al.

    Lancet

    (1977)
  • J. Jarrett

    Clin. Endocr. Metab.

    (1977)
  • H. Bar-On et al.

    Lancet

    (1977)
  • G.D. Calvert et al.

    Lancet

    (1978)
  • P. Durrington

    Lancet

    (1978)
  • J. Wingerd et al.

    Lancet

    (1978)
  • K. Stanton

    Lancet

    (1978)
  • G.J. Miller et al.

    Lancet

    (1975)
  • R.J. Garrison et al.

    Atherosclerosis

    (1978)
  • W.P. Castelli et al.

    Lancet

    (1977)
  • K. Yano et al.

    New Engl. J. Med.

    (1977)
  • P.N. Durrington et al.

    Clin. Chim. Acta

    (1976)
  • D.S. Fredrickson
  • M.C. Stone et al.

    Clin. Chim. Acta

    (1966)
  • E.G. Abraham et al.

    Diabetes

    (1978)
  • J.W. Gofman et al.

    Plasma

    (1954)
  • G.G. Rhoads et al.

    New Engl. J. Med.

    (1976)
  • Cited by (47)

    • Diabetic dyslipidaemia

      1999, Bailliere's Best Practice and Research in Clinical Endocrinology and Metabolism
    • Plasma and cellular zinc levels and membrane lipid composition in streptozotocin diabetic rats

      1989, Comparative Biochemistry and Physiology -- Part B: Biochemistry and
    View all citing articles on Scopus
    View full text